Delivery Order SPE2DB25D2204-SPE2DB25FTGUL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,436.56 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on July 28, 2025. This firm fixed-price delivery order, designated as contract 4568902309, is scheduled for completion by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,554.64 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Premarin 0.3 mg tablets (100-count units). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, to supply 1,000 tablets of Premarin 0.625 mg at a fixed price of $3,251.40, with completion scheduled for July 28, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Premarin 0.3 mg tablets (100-count units) with a ceiling value of $4,722.10. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for ultimate completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,600.44 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award is issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,385.11 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This non-set-aside contract was competitively awarded with a firm fixed price structure and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $8,454.01 contract is for the delivery of Premarin 0.9mg tablets to support military treatment programs. This delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the...
- This is a $2,763.81 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Premarin 0.9 mg tablets. The contract has a completion date of September 13, 2024 and is not set aside for any specific business category. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 units of the 0.3 mg tablet form of the pharmaceutical Premarin. The order has a potential value of $29,912.66 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGULDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The prime IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical vendor for federal medical procurement, with delivery orders covering diverse pharmaceutical products across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 7/29/25 |